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Box 20
erasmuAbstract—The vulnerable atherosclerotic plaque is believed to be at the root of the majority of acute coronary
events. Even though the exact origins of plaque vulnerability remain elusive, the thin-cap fibroatheroma, charac-
terized by a lipid-rich necrotic core covered by a thin fibrous cap, is considered to be the most prominent type of
vulnerable plaque. No clinically available imaging technique can characterize atherosclerotic lesions to the extent
needed to determine plaque vulnerability prognostically. Intravascular photoacoustic imaging (IVPA) has the
potential to take a significant step in that direction by imaging both plaque structure and composition. IVPA is
a natural extension of intravascular ultrasound that adds tissue type specificity to the images. IVPA utilizes the
optical contrast provided by the differences in the absorption spectra of plaque components to image composition.
Its capability to image lipids in human coronary atherosclerosis has been shown extensively ex vivo and has recently
been translated to an in vivo animal model. Other disease markers that have been successfully targeted are calcium
and inflammatorymarkers, such asmacrophages andmatrixmetalloproteinase; the latter two through application
of exogenous contrast agents. By simultaneously displaying plaque morphology and composition, IVPA can pro-
vide a powerful prognostic marker for disease progression, and as such has the potential to transform the current
practice in percutaneous coronary intervention. (E-mail: g.vansoest@erasmusmc.nl)  2014 World Federation
for Ultrasound in Medicine & Biology.
Key Words: Photoacoustic imaging, Intravascular ultrasound, Atherosclerosis, Vulnerable plaque, Tissue
characterization.
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The rupture of vulnerable atherosclerotic plaques is a ma-
jor contributor to acute cardiovascular events and sudden
cardiac deaths (Falk et al. 1995). In 2008, out of the 17.3
million cardiovascular deaths worldwide, heart attacks
were responsible for 7.3 million deaths (World Health
Organization 2008). The vulnerability of an atheroscle-
rotic plaque, its susceptibility to rupture, is known to be
related to the composition of the plaque, the distribution
of mechanical stress within it, and the presence and extent
of associated inflammation (Richardson et al. 1989;
Schaar et al. 2004; Virmani et al. 2000). One of the
most common types of vulnerable plaques is the thin-
cap fibroatheroma. These lesions are characterized by a
thin fibrous cap, weakened by the presence of macro-ddress correspondence to: Gijs van Soest, Department of
dical Engineering, Thorax Centre, Erasmus MC, Ee23.02, PO
40, 3000 CA Rotterdam, The Netherlands. E-mail: g.vansoest@
smc.nl
1037phages, covering a lipid-rich necrotic core (Schaar et al.
2004). Rupture of the cap due to high mechanical stress
will release the thrombogenic contents of the necrotic
core into the bloodstream. The subsequent formation of
a platelet-rich thrombus may result in occlusion, either
at the location of the rupture or downstream from the
lesion site. If this occlusion takes place in a coronary
artery, the result may be unstable angina or a myocardial
infarction. The key to plaque vulnerability is still elusive,
even though recent advances in intravascular imaging
technology have enabled the collection of a wealth of
data on unstable atherosclerosis in all its stages of de-
velopment (Waxman et al. 2006), both in clinical and
in ex vivo settings. Plaque type and morphology are rele-
vant for planning percutaneous coronary intervention
and significantly affect long-term treatment outcome
(Kolodgie et al. 2001).
The current standard for intravascular assessment of
coronary atherosclerotic disease and guidance of interven-
tional procedures is intra-vascular ultrasound (IVUS).
This modality produces images based on the reflected
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both lumen geometry and the structure of the vascular wall
with a resolution of approximately 100mmand an imaging
depth of 7 mm. IVUS is used in clinical practice and trials
to measure lumen dimensions, degree of stenosis, plaque
burden and to assess calcification and stent deployment.
As outlined above, plaque composition is a highly
relevant parameter for its vulnerability. Technologies
for imaging tissue type in the vessel wall are scant, how-
ever. The sensitivity and specificity of IVUS gray-scale
for plaque composition is limited (de Korte et al. 2000)
because the contrast between soft tissue types is minimal.
IVUS radio frequency data analysis techniques for tissue
characterization have been developed as an extension to
gray-scale imaging (Nair et al. 2002). Today, two com-
mercial IVUS systems offer coronary tissue characteriza-
tion: VH-IVUS (20 MHz, phased-array transducer;
Volcano Therapeutics, Rancho Cordova, CA, USA) and
iMap (40 MHz, mechanical-type transducer; Boston Sci-
entific, Fremont, CA, USA). VH-IVUS differentiates four
tissue types: necrotic core, fibrous, fibrofatty and dense
calcium (Garcia-Garcia et al. 2010) but has shown limited
accuracy in complex lesions in a porcine model (Granada
et al. 2007; Thim et al. 2010). iMap distinguishes similar
tissue types: fibrotic, lipidic, necrotic and calcified tissue.
An in vivo comparison between VH-IVUS and iMap
yielded a significant and systematic variability in plaque
composition estimates (Shin et al. 2011). These conflict-
ing observations have fueled an ongoing debate about the
appropriate interpretation of ultrasound-based tissue
characterization.
Intravascular optical coherence tomography
(IVOCT) is another modality based on the echo delay
of light backscattered from the tissue. IVOCT provides
high resolution images (15 mm) but with limited depth
penetration (1–2 mm) (Tearney et al. 2008). Flushing of
the artery under inspection is required due to the strong
signal attenuation through blood. Widespread clinical
acceptance was achieved after the introduction of high
frame rate (.100 frames per s) and pullback speed
(20–40 mm/s). Compared to IVUS, optical coherence
tomography (OCT) offers better assessment of lumen
geometry, fibrous cap thickness, stent structure, stent strut
coverage and detection of macrophages (Tearney et al.
2003, 2012). On the other hand, tissue characterization
by IVOCT is less straightforward and is currently a
topic of intense research (van Soest et al. 2010).
In the past decade, a number of other optical tech-
nologies have aimed to improve intra-vascular tissue
characterization. The most advanced in terms of clinical
penetration is near-infrared reflection spectroscopy
(NIRS), which is developed and commercialized by In-
fraredx Inc. (Burlington, MA, USA). It collects a reflec-
tion spectrum of the arterial wall, through blood, andidentifies the presence of lipid-core plaque in the artery
wall. Recently, our laboratory collaborated with In-
fraredx to develop a hybrid NIRS/IVUS catheter that
combines morphologic imaging and lipid detection
(Gardner et al. 2008; Garg et al. 2010; Moreno et al.
2002). This is the first multi-modality device to enter
the clinical arena (TVC, Infraredx). Combined interpre-
tation of IVUS and NIRS data may yield an assessment
of the lesion morphology. This also highlights a limita-
tion of NIRS: it is not an imaging modality. Because it
lacks depth resolution, NIRS can identify the presence
but not the amount or the location, relative to the lumen,
of the lipid core. The sensing depth of NIRS is not well
quantified.
Intravascular photoacoustics (IVPA) is the most
recent addition to spectroscopic diagnostic techniques
and is the topic of this review. IVPA has the ability to
directly image tissue components in the vessel wall,
with high chemical specificity for lipid type. There is po-
tential to extend the technology to identify other factors
such as dense macrophage infiltration, associated with
plaque vulnerability. The same catheter can be used
simultaneously to image the arterial wall architecture
by IVUS. A review by Wang et al. (2010b) laid out the
basics of IVPA; we focus here on developments that
have emerged since that work appeared.
Principle of photoacoustics
In photoacoustic (PA) imaging, the tissue is irradi-
ated by short laser pulses with a length of several nano-
seconds. Absorption of laser light transfers the optical
energy to the tissue, which causes a transient pressure
rise (Oraevsky and Karabutov 2003). This initial pressure
rise acts as an acoustic source that generates a broadband
wave propagating through the tissue. The acoustic wave
can be detected with an ultrasound transducer. An image
can be created by scanning either the ultrasound or the
optical beam and deriving depth resolution from the
time-of-flight of the ultrasound wave. Note that the
time-of-flight is one-way only because the propagation
delay of light is negligible. The prime advantage of
such an ultrasound-mediated image, generated by an
optical contrast mechanism, is that it provides the advan-
tages of both resolution and viewing depth of ultrasound
and chemical specificity of optical absorption.
In IVPA, this principle needs to be miniaturized to fit
on a catheter. Light is delivered through an optical fiber,
while signal detection is performed by the same type of
ultrasound transducer that is used in IVUS. The arrange-
ment of fiber and transducer must be such, that the tissue
within the field of view of the transducer is illuminated.
The small, unfocused single-element devices used in
IVUS offer the opportunity to create small catheters.
The principle of IVPA is shown in Figure 1.
Fig. 1. Sketch of the intravascular photoacoustic imaging
(IVPA) principle. A laser pulse (green) is sent from the catheter
(C) to the vessel wall containing a plaque (yellow). The light ex-
cites an acoustic wave (blue curves) through optical absorption
and the associated thermoelastic expansion (red star). The graph
on the right shows a time trace of the acoustic signal after the
laser fires at time t 5 0.
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tion p0 5 GmaF, where F is the optical energy density,
ma is the absorption coefficient and G 5 bc0/Cp is the
Gr€uneisen parameter. This number describes the
thermo-acoustic conversion efficiency and depends on
the thermal expansion coefficient b, the acoustic wave
velocity c0, and the specific heat at constant pressure
Cp. The variation of the absorption coefficient with the
excitation wavelength is the tissue-specific chemical ab-
sorption spectrum, which permits differentiation of tissue
type (Fig. 2). The PA excitation wavelengths can be
selected to give maximum absorption contrast between
the relevant components in the vessel wall and plaque,
such as collagen, calcified tissue, and lipids (Tromberg
et al. 2000; Van Veen et al. 2004), to image plaque900 1000 1100 1200 1300
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Fig. 2. Absorption spectra of various absorbers present in cor-
onary artery vessel wall. Water, fat, and connective tissue
(collagen and elastin) are the major contributors to the absorp-
tion spectra of human tissues in the near-infrared spectral region
(Tsai et al. 2001).composition using endogenous contrast. Alternatively,
exogenous absorbers can be utilized to generate
contrast for vulnerable plaque markers that would
otherwise remain invisible due to their relatively
featureless or low-amplitude absorption spectra. Macro-
phages are an example of such plaque components. Con-
ventional PA imaging often relies on blood as a
chromophore, which is a much more strongly absorbing
tissue than typical vessel wall components. Hence, the
signal strength in IVPA is generally small and transducer
sensitivity is an important requirement.Development of IVPA
Endogenous contrast: imaging of lipids and
calcification. The goal of IVPA imaging is the chemical
characterization of vessel wall components. Historically,
development has been driven by the availability of suit-
able light sources. For this reason, the first spectroscopic
measurements focused on the visible wavelength range
(410–680 nm) (Al Dhahir et al. 1990; Prince et al.
1986). Through PA imaging of human atherosclerotic
aorta specimens, contrast for lipids was found at 461
and 532 nm (Beard and Mills 1997) and contrast for cal-
cium at 308 nm (Crazzolara et al. 1991). Discrimination
between normal and atheromatous areas of arterial tissue
in the visible range has an important drawback, at these
wavelengths blood (hemoglobin) absorption is also very
high. Introduction of infrared sources prompted inves-
tigation of a wider range of excitation wavelengths
(680–1800 nm). Blood absorption is especially low in
the wavelength range from 680–1300 nm. In this wave-
length range, the absorption spectrum of lipids exhibits
a large peak around 1210 nm (Fig. 2). The group led by
Emelianov, pioneered spectroscopic IVPA to distinguish
between lipid-rich tissue and collagen (Sethuraman et al.
2008). They performed imaging of ex vivo normal and
atherosclerotic rabbit aorta samples using a bench-top
setup with a commercial IVUS catheter and external illu-
mination. They found different spectral slopes in the
IVPA image in regions identified as lipid-rich collagen
type I and collagen type III. The same group subsequently
exploited the absorption peak around 1210 nm to image
lipids in atherosclerotic rabbit aorta (Wang et al. 2010a).
Allen and Beard (2009) were the first to exploit the
low blood absorption in the near infrared to discriminate
between lipid-rich and normal vascular tissue while im-
aging through several millimeters of blood (Allen et al.
2012). Imaging through blood is difficult because of the
strong attenuation of the excitation light. They investi-
gated samples of atherosclerotic human aorta and
confirmed the presence of lipids by comparing the PA
spectra obtained in a region within the plaque to the spec-
tral signature of a lump of fat.
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yielded an additional lipid specific absorption feature
around 1720 nm (Allen and Beard 2009). Bo Wang
et al. (2012b) imaged an atherosclerotic rabbit aorta
ex vivo in the presence of luminal blood using excitation
light at that wavelength. They demonstrated single wave-
length IVPA imaging of lipids through blood using rela-
tively low laser output energy. However, the specificity
of this single wavelength method for lipids in human
atherosclerotic plaques remains to be investigated.
The first demonstration of in vivo IVPA was per-
formed using the same 1720 nm single wavelength in a
hypercholesterolemic rabbit model (Wang et al. 2012a),
see Figure 3. The study was limited by the slow laser sys-
tem, which necessitated a complex breath gating acquisi-
tion. It did show, however, that in vivo imaging without
flushing the blood from the artery is possible.
In most IVPA experiments, lipid rich atherosclerotic
plaques were distinguished from normal arterial tissue by
simply comparing the tissue spectral signature to the ab-
sorption spectra of lipids. A more sophisticated spectros-
copy inversion approach could provide robust
identification of a wider range of tissue types, including
collagen, elastin and calcifications. Pu Wang et al.
(2012c) recorded spectroscopic PA data of a phantom
consisting of rat-tail tendon and fat between 1650–
1850 nm. A multi-variate curve fit analysis yielded the
spatial distribution of collagen and lipids in the phantom.
Photoacoustic generation is temperature dependent,
and the dependence is tissue specific, which provides
another contrast mechanism. With increasing tissue tem-
perature, the PA amplitude of atherosclerotic plaque
lipids decreased while the PA amplitude of peri-
adventitial lipids and abdominal fat remained relatively
constant between 20–38C (Wang and Emelianov
2011). Thermal IVPA imaging of atherosclerotic lipidsFig. 3. In vivo IVPA/intravascular ultrasound (IVUS) imaging
(b) combined IVPA/IVUS image. The location of lipid deposi
IVUS image. Adapted fromhas the advantage over spectroscopic IVPA that only
one wavelength is needed. However, creating reliable
temperature differences in vivo might prove difficult.
IVPA imaging of human coronary atherosclerosis. In
2011, we reported the first IVPA imaging of human
atherosclerotic coronary arteries ex vivo (Jansen et al.
2011). Specific imaging of lipids was shown by spectro-
scopic imaging over the wavelength range 715–1400 nm,
making use of the peak in the lipid absorption spectrum
around 1210 nm. This distinct peak was used to differen-
tiate lipids from other tissue components of the vessel
wall. In contrast to earlier work, an actual prototype
IVPA catheter, with intra-vascular illumination of tissue,
was used to image the arteries. Fresh human coronary ar-
teries, showing different stages of disease, were imaged
ex vivo by co-registered IVPA/IVUS. A result is shown
in Figure 4 (a). The histology shows circumferential
intimal thickening with a large eccentric lipid-rich lesion,
as well as a calcified area and regions of peri-adventitial
fat. The IVUS data confirms this morphology. The IVPA
image at 1210 nm exhibits a bright signal along the
intimal border, as well as from deeper tissue layers in
the eccentric plaque and the peri-adventitial fat in the bot-
tom right corner. At 1230 nm, the signal in these regions
is markedly lower, in accordance with the absorption
spectrum of lipids in this wavelength range. Collocated
with the enhanced 1210 nm IVPA signal a positive Oil
Red O stain is observed, particularly in the plaque, indi-
cating the presence of lipids. Since the variation in the
laser pulse energy and tissue scattering properties is
negligible over the wavelength range 1210–1230 nm,
the light fluence at every location could be assumed
equal. Photoacoustic spectra were acquired along image
lines sampling the plaque tissue. In Figure 4 (b), the
spectra at three locations are shown, two inside theof lipid in an abdominal rabbit aorta. (a) IVPA image and
ts in the vessel wall is visualized in the combined IVPA/
Wang et al. (2012a).
Fig. 4. IVPA/IVUS imaging of an advanced human atherosclerotic plaque. IVPA images at (a) 1210 nm (high lipid
absorption) and (b) 1230 nm (low lipid absorption). (c) IVUS image. Full spectral scans were made along the blue
line in (a) and (b). Arrowheads indicate the needle used for marking. (d) Histology: Oil Red O stain shows the presence
of a lipid-rich plaque (*) as well as a calcified area (Ca). Lu, lumen; Pf, peri-adventitial fat. (e) Photoacoustic spectra at
three locations on the blue line in (a) and (b), indicated by the blue dots. The sites at 1.4- and 1.7-mm distance from the
catheter are located within the lipid-rich plaque. The corresponding photoacoustic (PA) spectra show strong resemblance
to the lipid absorption reference. The site at 2.2 mm is located just outside the plaque area. Adapted from Jansen
et al. (2011).
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tion spectra of lipids and connective tissue (Tsai et al.
2001) are included for reference. The two spectra located
in the plaque clearly match the lipid reference, while the
third lacks the pronounced peak.
Automatic spectroscopic IVPA detection of lipids
(Fig. 5) can be achieved using the same catheter and
experimental setup. Co-registered cross-sectional IVPA/
IVUS scans of fresh ex vivo human coronary arteries
from 1185–1235 nm at 10 nm intervals were acquired.
For each pixel in the resulting data set, we computed
the correlation of the IVPA spectra with a reference lipid
absorption spectrum. The lipid matching regions—those
with a correlation coefficient equal to or higher than an
empirically chosen threshold—exhibited good corre-
spondencewith the histologic lipid stain of the same cross
section (Fig. 5c and d). These experiments provide proof
of principle for robust IVPA imaging of plaque composi-
tion with as few as three different wavelengths (Jansen
et al. 2013).
IVPA imaging at 1720 nm was also demonstrated on
human coronary atherosclerosis ex vivo (Wang et al.
2012a). Working at a single wavelength has advantages
of speed and simplicity of the laser source but risks losing
chemical specificity. We recently compared the 1.2 mm
and 1.7 mm wavelength bands and found that both are
suitable for imaging lipids in atherosclerosis (Jansen
et al. 2014). The chemical specificity of either wave-
length range, as well as the potential for imaging withfew wavelengths needs to be confirmed in more elaborate
studies.
Exogenous contrast: imaging of macrophages and
matrix metalloproteinase. Vulnerable plaque markers
that lack sufficient endogenous contrast can be imaged
using exogenous absorbers. Macrophages are an example
of such plaque components. They do not provide endog-
enous contrast but can be visualized using gold nanopar-
ticles. The gold nanoparticles have a distinct absorption
peak in the visible wavelength range. When the nanopar-
ticles are endocytosed by macrophages, they aggregate.
These aggregated gold nanoparticles have a shifted
peak in the absorption spectrum compared to the (extra-
cellular) non-aggregated gold nanoparticles, providing
image contrast. This principle was proven in an athero-
sclerotic rabbit aorta injected with macrophages loaded
with gold nanoparticles in a bench-top experimental
setting (Wang et al. 2009). The resulting IVPA images,
shown in Figure 6, demonstrate that the aggregated
gold nanoparticles produce the strongest PA signal at
700 nm wavelength. The extravasation of nanoparticles
in atherosclerotic regions with compromised luminal
endothelium and acute inflammation was shown by sys-
temic injection of gold nanoparticles in a live rabbit
model, followed by ex vivo IVPA imaging (Yeager et al.
2012). IVPA/IVUS imaging at 750 nm revealed a high
PA signal from localized gold nanoparticles in regions
with atherosclerotic plaques.
Fig. 5. Combined IVPA/IVUS images at (a) 1205 nm and (b) 1235 nm of a human coronary artery with low-grade dis-
ease. (c) Automatic lipid detection image overlaid on IVUS image. (d) Lipid histology stain (ORO). Adapted from Jansen
et al. (2013).
1042 Ultrasound in Medicine and Biology Volume 40, Number 6, 2014Matrix metalloproteinase (MMP) activity, an indica-
tor of plaque instability, can be detected using a MMP-
activatable fluorescent imaging agent. MMPSense
(MMPSense 680; VisEn Medical, Boston, MA, USA) is
such an imaging agent and is activated by different en-
zymes, most prominently MMP2/9 and trypsin, and to a
lesser extent by other proteases. Once activated, it be-
comes optically absorbing. More than 80% of the ab-
sorbed energy is transferred into PA signals, due to the
low quantum yield of the dye. It has a much lower absorp-
tion than gold nanoparticles and thus produces a much
lower PA signal intensity.
MMPSense was used for detecting MMP activity in
human carotid arteries (Razansky et al. 2012). Immedi-
ately after endarterectomy, the atherosclerotic specimens
were incubated in MMPSense. The morphologic PA im-
ages, shown in Figure 7 (a, c, e), were obtained using a
small-animal imaging system. The activated probe was
distinguished from the background and the inactive
probe, by acquiring PA data at several wavelengths and
analyzing spectral contributions on a per-pixel basis.
The results matched well with fluorescence microscopy
(Fig. 7b, d, f).IVPA catheter development
Practical in vivo implementation of IVPA requires
the development of a dedicated catheter device. Such a
device needs to incorporate an optical axis to deliver the
light to the vessel wall and an ultrasound detector to detect
the PA signals. Various designs have been proposed.
A miniature, all-optical IVPA probe based on a
Fabry-Perot ultrasound sensor was built (Zhang and
Beard 2011). It had a diameter of only 250 mm and ex-
hibited good acoustic sensitivity. This all-optical design
of an IVPA imaging probe lacks IVUS functionality but
has the potential for multi-modal operation and could
be combined with OCT and other optical imaging and
sensing methods.
Devices that contain a piezoelectric ultrasound
transducer for detection of PA signals can be used for
combined IVPA/IVUS imaging to provide simultaneous
information on composition and morphology of the arte-
rial wall. Two early prototype catheters combined an op-
tical fiber for light delivery with a commercially available
IVUS imaging catheter (Atlantis SR plus, Boston Scien-
tific, Inc.) for both pulse-echo ultrasound imaging and
detection of PA signals (Karpiouk et al. 2010). Light
Fig. 6. Combined IVPA/IVUS images at 700, 750 and 800 nm (a-c) and IVUS image (d) of a diseased rabbit aorta in-
jected with macrophages loaded with gold nanoparticles (blue arrows). The combined IVPA/IVUS images taken at
700 nm wavelength (a) showed high photoacoustic signal at the injected regions denoted by arrows. Adapted from
Wang et al. (2009).
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polished fiber (‘‘side-fire fiber’’) or a silver-coated glass
mirror.
A step toward an array catheter for PA imaging anal-
ogous to Volcano’s electronic IVUS catheter was made
(Hsieh et al. 2010). When using omni-directional optical
excitation and ultrasound transmission and detection, no
rotation is needed and the required laser pulse repetition
rate is reduced. A prototype of a catheter with omni-
directional light delivery consisted of a multi-mode opti-
cal fiber coupled to a cone-shaped mirror for illumination
and an optical ultrasound detector. The outer diameter of
the device was 3 mm.
Early integrated IVPA catheters were too large to
use in human coronary arteries, and have only been tested
on phantoms, rabbit aortas and human arteries that were
opened up to enable en-face scanning of the luminal sur-
face. Recently, we achieved a vital step toward miniatur-
ization of IVPA devices by building a hybrid IVPA/IVUS
catheter with an outer diameter of 1.25 mm. The catheter
consisted of a 400-mm diameter core optical fiber and an
IVUS transducer with a diameter of 1.0 mm (Jansen et al.
2010). A schematic illustration and a photograph of the
catheter tip are shown in Figure 8 (a and b), respectively.The tip of the fiber was polished at an angle of 34 and
covered with a glued-on quartz cap to preserve an air-
glass interface deflecting the beam by total reflection.
The transducer had a wide frequency bandwidth centered
at 30 MHz. The fiber and the transducer were mounted in
a tip assembly (Fig. 8b). Using this probe, we imaged
intact human coronary arteries ex vivo (Jansen et al.
2011).
A variation on this design used a side-firing optical
fiber and side-viewing ultrasonic transducer arranged
side-by-side (Li et al. 2012). The fiber and transducer
were packaged in polyimide tubing with an outer diam-
eter of 1.2 mm; making it the smallest catheter to date
that combines IVPA and IVUS imaging. The arrangement
of the fiber and transducer minimizes the offset of the
beams, which may improve the optical–acoustic overlap-
ping, especially close to the probe.
The probes described previously all derive their
transverse imaging resolution from the acoustic beam
properties: light is assumed to be diffuse and excite a
PA signal throughout a large area, part of which is
sampled by the acoustic beam. Optical-resolution PA im-
aging (Maslov et al. 2008) provides better transverse res-
olution, as light can be focused to a smaller diameter than
Fig. 7. Localization of matrix metalloproteinase (MMP) activity in three carotid specimens. Samples 1 (top row) and 2
(middle row) were incubated in MMPSense 680 while sample 3 (bottom row) was incubated in PBS. (a), (c) and (e): PA
imaging results of intact plaques. Cross-sectional spectroscopic reconstruction, revealing location of MMPSense 680 ac-
tivity in the slice, is shown in green color that is superimposed onto morphologic photoacoustic images. (b), (d) and (f):
The corresponding epi-fluorescent images from dissected plaque (in green) superimposed onto color images of cryosec-
tions from the three carotid plaque specimen. Adapted from Razansky et al. (2012).
1044 Ultrasound in Medicine and Biology Volume 40, Number 6, 2014ultrasound at diagnostic frequencies. The resolution
advantage comes at the cost of viewing depth, which is
necessary to create cross-sectional images. This limits
the use of optical-resolution approaches for intra-
vascular imaging.DISCUSSION
IVPA is an experimental technique that is currently
being developed in ex vivo experiments, undergoing
continuous further refinement. Although it has shown
the ability to fill an important niche, many facets of
real-time clinical imaging still need to be resolved.
Several important aspects of the optimal image acquisi-
tion sequence, laser sources, catheter design, etc., arecurrently under investigation. The road to in vivo IVPA
imaging will present some specific challenges that we
discuss below.
In order to obtain optimal PA signal strength, it is
desirable to deliver as much light to the vessel wall as
possible within the physical boundaries of the instrument
and within the safety limits. Blood is a strongly scattering
tissue, which can markedly reduce the light intensity at
the vessel wall, even at wavelengths in the near infrared
region. Several ex vivo IVPA experiments have shown
IVPA imaging through blood (Allen and Beard 2009;
Allen et al. 2012; Wang et al. 2012a, 2012b) but the
image quality deteriorates considerably in the presence
of luminal blood. Even when imaging at 1720 nm, at
very high lipid absorption, the image quality and
Fig. 8. (a) Detailed schematic of the catheter tip of a combined
IVUS/IVPA catheter, showing the beam layout (light beam in
red; US beam in green). (b) Photograph of the catheter tip on
the edge of a 10 eurocent coin. The outer diameter of the cath-
eter tip is 1.25 mm (white arrows). Adapted from Jansen et al.
(2011).
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would be greatly improved by flushing. It therefore
appears likely that IVPA imaging may involve flushing
of the blood from the artery in the clinical setting.
Blood clearing is standard practice in IVOCT imaging.
Unlike IVOCT, IVPA does not rely on the complete
suppression of scattering in the lumen, but only requires
the delivery of sufficient power. This means that
dilution, rather than complete clearing, may be good
enough. On the other hand, the ultrasonic properties of
the flush media used for OCT (iodixanol, a coronary
angiography contrast agent, trade name Visipaque (GE
Healthcare, Princeton, NJ, USA)) are not precisely
known, so investigation of alternatives may be needed.
IVPA poses a set of strict requirements on the light
source. Lasers used in development of the technology
are powerful and versatile, but slow at pulse repetition
rates of 10–50 Hz. This low pulse frequency precludes
in vivo imaging. Particularly if flushing is used, theoptimal imaging sequence will be modeled on that of
Fourier domain OCT: high frame rate, high pullback
speed, short pullback time of,10 s. This acquisition pro-
tocol prescribes a light source with a repetition rate of the
order of 10 kHz, with wavelengths that generate relevant
contrast. Such lasers are currently being developed (Li
et al. 2013).
The smallest combined IVPA/IVUS catheter diam-
eter built to date has a diameter of 1.2 mm. Current
IVUS probes have an outer diameter of less than 1 mm,
including the protective sheath in which they rotate.
Future developments will reduce the IVPA catheter diam-
eter to 1 mm or less for successful application in clinical
practice. All-optical devices are much smaller but sacri-
fice IVUS functionality. As in ultrasound imaging, both
bandwidth (for axial resolution) and sensitivity are
important parameters for transducer selection. The small
signal strength in IVPA means that sensitivity should be
considered the more critical of the two. Most devices
demonstrated to date work in the frequency range that
is also used for IVUS. There is no experimental data to
support that this range is actually optimal. Further optimi-
zation of transducers needs to be part of the effort to bring
IVPA to clinical applicability.
IVPA is undergoing rapid development to become a
clinically viable technology. Table 1 gives an overview of
the advantages and disadvantages of the different intra-
vascular imaging modalities and their capacity to detect
the different markers of plaque vulnerability. There is
no single technique that can determine plaque vulnera-
bility completely, which is why multi-modality imaging
is frequently proposed. IVPA can differentiate between
plaque components by using the differences in the optical
absorption spectra of different tissues, like NIRS. Howev-
er, unlike NIRS, it has depth resolution, which makes it
possible to know the exact spatial location of the lipids
relative to the lumen border. IVPA provides optical
contrast with ultrasound imaging depth. If used in combi-
nation with IVUS, IVPA can provide information on pla-
que composition that complements the morphologic
information provided by IVUS. In the future, useful com-
binations with other imaging modalities are likely to be
explored such as an IVPA/OCT combination.
IVPA can potentially become a very powerful tool
for guidance of percutaneous coronary intervention, in-
forming the decision of which plaque to treat and length
to stent with detailed composition information. The
occurrence of incomplete stent coverage of lipid-rich
plaques, despite adequate coverage of the angiographic
stenosis, demonstrates the limitations of standard angiog-
raphy to delineate the borders of the plaque. Incomplete
stent coverage can potentially cause lipid-rich plaque
disruption during stent placement, which can result in
distal embolization (Schultz et al. 2010). Incomplete stent
Table 1. Intravascular imaging modalities: strengths and weaknesses compared
Image
Grayscale IVUS VH-IVUS/iMap Palpography NIRS IVOCT IVPA
Cross-section structure Cross-section tissue type Radial strain map (elastogram) Lipid-core plaque map (chemogram) Cross-section structure Cross-section tissue type
Type of radiation Ultrasound Ultrasound Ultrasound Near-IR light Near-IR light (Near-IR) light 1 ultrasound
Axial resolution (mm) 100–200 .250 450 N/A 10–15 100
Lateral resolution (mm) 300–500 300–500 300–500 1000 30–40 400–500
Penetration (mm) 10 5 N/A unknown 1 5
Contrast mechanism Acoustic scattering Acoustic
Spectrum
Tissue strain Optical absorption Optical scattering Optical absorption
Pullback rate 0.5 mm/s 0.5 mm/s 0.5 mm/s 0.5 mm/s 20–40 mm/s N/A*
Flushing no No no no Yes TBDy
Current status CS/CA CS/CA CS CS/CA CS/CA PCS
Lumen area 11 11 2 2 11 6
Plaque burden 11 11 2 2 2 6
Positive remodeling 11 11 2 2 2 6
Necrotic core 6 11 11 11 2 11
Fibrous-cap thickness 2 2 2 2 1 2
TCFAz 2 6 11 2 1 6?
Plaque rupture 1 1 2 2 11 2
Erosion 2 2 2 2 1 2
Thrombus 6 6 2 2 1 2
Inflammation 2 2 2 2 6 6?
Calcium 11 11 11 2 1 2
IVUS 5 intravascular ultrasound; VH 5 virtual histology; NIRS 5 near-infrared spectroscopy; IVOCT 5 intravascular optical coherence tomography; NIRF 5 near-infrared fluorescence;
IVPA 5 intravascular photoacoustics; CA 5 clinically, commercially available; CS 5 clinical studies; PCS 5 pre-clinical studies; N/A 5 not applicable; TBD 5 to be determined; TCFA 5 thin-cap
fibroatheroma.
11excellent.
1good.
6possible.
2impossible.
Data derived from Kubo and Akasaka (2012), Suh et al. (2011), MacNeill et al. (2003) and Maehara et al. (2009). Palpography data derived from Schaar et al. (2006).
*Current experimental IVPA/IVUS imaging systems are using a 10-Hz repetition rate laser. Pullback rate is calculated for using four wavelengths, 300 A-scans per slice and a step size of 200 mm.
y May not be required in specific wavelength bands (e.g., the near-infrared window).
z The positive predictive value to detect ‘‘definite TCFA’’ (defined as agreement by both OCT and VH-IVUS) was 78% by OCT but only 46% by VH-IVUS by Sawada et al. (2008).
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Intravascular photoacoustic imaging and plaque identification d K. JANSEN et al. 1047coverage is also suspected to be associated with plaque
progression leading to stent failure due to edge restenosis
(Waxman et al. 2010). IVPAwill also contribute to studies
of plaque vulnerability and allows quantification of the
response to different forms of intervention (device, phar-
macologic, lifestyle changes) with high chemical detail
in vivo. IVPA could provide an imaging endpoint in
clinical studies to show changes in the lipid content of
atherosclerotic plaques (Serruys et al. 2008; Van
Mieghem et al. 2006).Acknowledgments—This work was funded by the Dutch Technology
Foundation (STW) through the 2007 Simon Stevin Meester grant
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